TRV GP, LLC
CIK 1578973 · last filed 2018-09-04
TRV GP, LLC is a corporate insider who has filed 7 SEC Form 4 insider transactions across 5 companies since 2013. The most recent filing, for RYTM, was dated Sep 4, 2018. Across all open-market trades the lifetime net is −$13.4M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $11.5M across reported positions. The firm reports its address in Boston, MA. 40 SEC filings were submitted jointly with THIRD ROCK VENTURES LP.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
BLUE price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
29 NEWBURY STREET, 3RD FLOOR
BOSTON, MA 02116
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| RYTM | 10%+ Owner | 99,105 | $113.95 | $11.29M | $0 | 1 | 2018-09-04 |
| CTMX | 10%+ Owner | 89,292 | $1.98 | $176.8K | $0 | 1 | 2017-07-13 |
| Larimar Therapeutics, Inc. (ZFGN) Delisted | 10%+ Owner | 0 | — | — | $0 | 1 | 2015-05-18 |
| Carisma Therapeutics Inc. (EBIO) Delisted | 10%+ Owner | 4,290,109 | — | — | $0 | 1 | 2014-02-13 |
| bluebird bio, Inc. (BLUE) Delisted | 10%+ Owner | 120,849 | $4.97 | $600.6K | -$13.42M | 3 | 2014-01-23 |
Recent Filings
7 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2018-09-04 | RYTM | Other (J) | −1,000,000 | $0 | EDGAR |
| 2017-07-13 | CTMX | Other (J) | −850,000 | $0 | EDGAR |
| 2015-05-18 | Larimar Therapeutics, Inc. (ZFGN) Delisted | Other (J) | −1,000,000 | $0 | EDGAR |
| 2014-02-13 | Carisma Therapeutics Inc. (EBIO) Delisted | Mixed | +4,510,883 | $8.1K | EDGAR |
| 2014-01-23 | bluebird bio, Inc. (BLUE) Delisted | Sell (S) | −250,000 | -$5.98M | EDGAR |
| 2014-01-14 | bluebird bio, Inc. (BLUE) Delisted | Sell (S) | −340,000 | -$7.45M | EDGAR |
| 2013-06-26 | bluebird bio, Inc. (BLUE) Delisted | Conv (C) | +4,734,248 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.